Abstract

Objective: We aimed to investigate relationships between sleep disturbances and phenoconversion to neurodegenerative diseases in patients with REM sleep behavior disorder (RBD). Method: Using a comprehensive sleep database in a university-affiliated hospital between December 2014 and March 2021, we reviewed the data of 226 patients with RBD (182 patients with idiopathic RBD (iRBD) and 44 patients with symptomatic RBD (sRBD) with a neurodegenerative disease). Results: Among 226 patients with RBD (male, 61.5%), the mean age at RBD onset and mean disease duration were 59.4 ± 10.5 and 5.9 ± 5.6 years, respectively. Further, 111 (49.1%) patients had periodic limb movements during sleep (PLMS, PLM index ≥ 15/h), while 110 patients (48.7%) had comorbid obstructive sleep apnea (OSA, respiratory disturbance index ≥ 15/h). There was a positive correlation between age at RBD onset and the apnea-hypopnea index and Pittsburgh Sleep Quality Index. Compared to patients with iRBD, patients with sRBD showed a lower N3 sleep (3.3 ± 5.0 vs. 1.6 ± 3.1%, p = 0.004) and higher periodic limb movement index (36.3 ± 31.8 vs. 56.9 ± 47.5/h, p = 0.021) at the baseline. Among the 186 patients with iRBD, 18 (8.0%) developed neurodegenerative diseases (converters, mean follow-up duration: 2.5 ± 1.6 years) and 164 did not (non-converters, mean follow-up 2.4 ± 2.2 years). There was no significant between-group difference in the demographics and baseline clinical features. Continuous positive airway pressure (CPAP) therapy was prescribed in 101 patients with OSA; among them, 71 (70%) patients agreed to use it. CPAP improved dream enactment behaviors. Conclusion: In our study, 8.0% of patients with iRBD showed phenoconversion within a mean follow-up duration of 2.5 years. Polysomnographic parameters could not predict phenoconversion to neurodegenerative disease. However, approximately half of the patients with RBD presented with significant sleep disorders, including OSA or PLMS. CPAP therapy may alleviate RBD symptoms in patients with RBD-OSA.

Highlights

  • Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by repeated episodes of sleep-related vocalization and/or complex motor behaviors during REM sleep

  • Often does not involve concomitant neurological conditions while sRBD is related to identifiable underlying etiologies [5], including α-synuclein pathology and other neurodegeneration forms, pontine lesions, and toxic effects of medications. Both iRBD and sRBD are generally associated with neurodegenerative diseases, especially α-synucleinopathies, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) [2,6,7,8]

  • 182 (80.5%) and 44 (19.5%) patients were diagnosed with iRBD and sRBD, respectively.The diagnosed neurological disorders were PD (n = 11), MSA

Read more

Summary

Introduction

Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by repeated episodes of sleep-related vocalization and/or complex motor behaviors during REM sleep. IRBD often does not involve concomitant neurological conditions while sRBD is related to identifiable underlying etiologies [5], including α-synuclein pathology and other neurodegeneration forms, pontine lesions, and toxic effects of medications. Both iRBD and sRBD are generally associated with neurodegenerative diseases, especially α-synucleinopathies, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) [2,6,7,8]. RBD is found in non-synucleinopathies such as tauopathy, including progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) [9]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call